开始和停止与自杀行为有关的精神药物:一项基于丹麦登记册的研究
Mette Reilev1,2,3, Jacob Harbo Andersen2, Mikkel Højlund3
1Centre for Suicide Research, Odense, Denmark.
Acta psychiatrica Scandinavica
|February 25, 2025
概括
心理药物使用在自杀和自杀未遂之前显著增加. 虽然在尝试之前完全停止治疗是很低的,但近一半的人停止饮酒滥用药物,突出了预防自杀的处方机会.
科学领域:
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 了解关于自杀行为的心理药物使用模式对于及时的预防性干预至关重要.
- 以前的研究还没有完全阐明药物开始/停止和自杀事件之间的时间关系.
研究的目的:
- 描述与自杀和自杀企图有关的精神药物治疗的开始和停止模式.
- 根据药物使用趋势,确定潜在的干预窗口.
主要方法:
- 利用丹麦国家登记处分析了自杀未遂前,自杀未遂后以及自杀前2年的精神药物使用 (事件和流行).
- 在自杀和自杀未遂之前的6个月内,估计的戒药率.
- 按药物类别,性别和年龄分层分析.
主要成果:
- 在自杀和自杀未遂之前的6个月内,观察到心理药物使用的明显增加.
- 药物赎回率最高的发生在自杀未遂后立即发生.
- 虽然总体中断率很低,但48%的人在自杀事件发生之前停止了滥用酒精的药物.
结论:
- 心理药物处方模式表明,预防自杀有潜在的机会,特别是在自杀行为发生的时候.
- 这些发现强调了需要仔细监测药物坚持和潜在的停药,特别是对酒精滥用治疗的需要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
176
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
176
01:26Psychosis: Goals of Pharmacotherapy
102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
01:28Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34
01:28Psychosis and Antipsychotic Drugs: Overview
171
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
171
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
69
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
69
01:19Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764